318 related articles for article (PubMed ID: 23134357)
1. Regulating compounding pharmacies after NECC.
Outterson K
N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
[No Abstract] [Full Text] [Related]
2. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
3. Toward Better-Quality Compounded Drugs - An Update from the FDA.
Woodcock J; Dohm J
N Engl J Med; 2017 Dec; 377(26):2509-2512. PubMed ID: 29281577
[No Abstract] [Full Text] [Related]
4. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
[TBL] [Abstract][Full Text] [Related]
5. Drug compounding, drug safety, and the first amendment.
Dresser R
Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
[No Abstract] [Full Text] [Related]
6. Under scrutiny. More control of compounding pharmacies sought.
Lee J
Mod Healthc; 2012 Oct; 42(43):12-3. PubMed ID: 23163094
[No Abstract] [Full Text] [Related]
7. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy - United States, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(41):839-42. PubMed ID: 23076093
[TBL] [Abstract][Full Text] [Related]
8. Compounding errors.
Drazen JM; Curfman GD; Baden LR; Morrissey S
N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
[No Abstract] [Full Text] [Related]
9. FDA inspections find unsafe practices in compounding pharmacies.
McCarthy M
BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
[No Abstract] [Full Text] [Related]
10. Learning about the safety of drugs--a half-century of evolution.
Avorn J
N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034
[No Abstract] [Full Text] [Related]
11. CDC probes new outbreak associated with compounded steroids.
Kuehn BM
JAMA; 2013 Jun; 309(24):2541. PubMed ID: 23800915
[No Abstract] [Full Text] [Related]
12. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
13. Iatrogenic fungal meningitis: tragedy repeated.
Perfect JR
Ann Intern Med; 2012 Dec; 157(11):825-6. PubMed ID: 23080380
[No Abstract] [Full Text] [Related]
14. American roulette--contaminated dietary supplements.
Cohen PA
N Engl J Med; 2009 Oct; 361(16):1523-5. PubMed ID: 19812394
[No Abstract] [Full Text] [Related]
15. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
16. Regulating Compounding Pharmacies.
Noble A
NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
[No Abstract] [Full Text] [Related]
17. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.
Miller DG
Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246
[No Abstract] [Full Text] [Related]
18. Multistate fungal meningitis outbreak -- interim guidance for treatment.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(41):842. PubMed ID: 23076094
[TBL] [Abstract][Full Text] [Related]
19. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
20. FDA milestones.
FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
